scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2567.2011.03507.X |
P698 | PubMed publication ID | 22044285 |
P50 | author | Mihai Netea | Q24517868 |
Xuehui He | Q56452144 | ||
P2093 | author name string | Frank Preijers | |
Irma Joosten | |||
Hans J P M Koenen | |||
André J A M van der Ven | |||
Meta Michels | |||
Rob Woestenenk | |||
Ai-Leng Khoo | |||
P2860 | cites work | Vitamin D controls T cell antigen receptor signaling and activation of human T cells | Q28275206 |
DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 | Q28285583 | ||
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice | Q28581280 | ||
Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile | Q33301251 | ||
Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy | Q33373073 | ||
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis | Q33493067 | ||
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. | Q33606850 | ||
Regulatory T cells in the control of immune pathology. | Q34348983 | ||
Vitamin D: its role and uses in immunology | Q34451101 | ||
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease | Q34556560 | ||
Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA | Q34575360 | ||
The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents | Q34583816 | ||
Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol) | Q34617856 | ||
Regulatory T cells in transplantation tolerance | Q35092535 | ||
Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. | Q35963620 | ||
Regulatory T cells and tumor immunity | Q36114473 | ||
Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts | Q36208185 | ||
In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease | Q36430929 | ||
Vitamin D physiology | Q36430932 | ||
Vitamin D: its role in cancer prevention and treatment | Q36432932 | ||
A potential role for vitamin D on HIV infection? | Q36505204 | ||
Control of autoimmune diseases by the vitamin D endocrine system | Q37204961 | ||
1,25-dihydroxyvitamin D3 selectively reduces interleukin-2 levels and proliferation of human T cell lines in vitro | Q41576405 | ||
Gene regulation by 1,25-dihydroxyvitamin D3 in CD4+CD25+ cells is enabled by IL-2. | Q43007160 | ||
1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses | Q43199222 | ||
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. | Q43290336 | ||
Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis | Q43440450 | ||
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. | Q43775059 | ||
Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells | Q44007127 | ||
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells | Q44448880 | ||
The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells | Q44521617 | ||
Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. | Q46030799 | ||
Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. | Q54613192 | ||
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system | Q66829131 | ||
1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro | Q67280107 | ||
Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells | Q73709030 | ||
P433 | issue | 4 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 459-468 | |
P577 | publication date | 2011-12-01 | |
P1433 | published in | Immunology | Q15754984 |
P1476 | title | 1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells | |
P478 | volume | 134 |
Q34744383 | 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial |
Q35981603 | 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region |
Q39386071 | 25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study. |
Q34076892 | 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings |
Q36494694 | Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses |
Q38255387 | Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies |
Q36353718 | Calcitriol modulates the CD46 pathway in T cells |
Q35154069 | Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings |
Q36218302 | Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome |
Q41832613 | Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells |
Q36237164 | Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis |
Q39356640 | High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells |
Q38798523 | Host and Environmental Factors Influencing Individual Human Cytokine Responses |
Q50673352 | No association between vitamin D and β-cell autoimmunity in Finnish and Estonian children. |
Q86931781 | Pharmacological and pharmacokinetic studies with vitamin D-loaded nanoemulsions in asthma model |
Q26774600 | Protective links between vitamin D, inflammatory bowel disease and colon cancer |
Q36085086 | The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases |
Q36723173 | The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus |
Q60916990 | Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough |
Q34550631 | Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. |
Q54319905 | Vitamin D status is not associated with inflammatory cytokine levels during experimental human endotoxaemia. |